Therefore, this study aimed to investigate the roles and mechanisms of CSNK2A1-SIRT6-DNA damage repair pathways in the treatment of osteosarcomas, especially those resistant to anti-cancer therapy. This evidence concerns the gene CSNK2A1 and osteosarcoma.